ImClone Systems Incorporated to Host Investor Reception on June 5, 2007 Following a Clinical Science Symposium Session about EGFR as a Therapeutic Target in GI Malignancy

NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL) announced today that the Company will host an investor reception on Tuesday, June 5, 2007 from 3:45 P.M. to 5:00 P.M. Central Time in the Conference Center, Room 11A at the Hyatt Regency McCormick Place Hotel (2233 South Martin Luther King Drive, Chicago, IL) following the conclusion of the 2007 Annual Meeting of the American Society of Clinical Oncology (ASCO).
MORE ON THIS TOPIC